Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now

Uta Kemmerich-Keil is the head of Merck's corporate finance more

German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday.

"You will not see us involved in transactions of (Millipore's) size in the short term," the company's head of corporate finance, Uta Kemmerich-Keil, said at an event, adding that management's focus was on integrating the laboratory equipment supplier.

Merck agreed to buy U.S. biotech tool maker Millipore for $6 billion in cash in February to diversify away from its pharmaceuticals business.

Related Articles :

• Q1 2012: Merck Total Revenues Increase 3.2% to €2.6 Billion
• New J&J CEO Parachuting Into Tough Terrain
• Celesio to Raise Stake in Brazil's Panpharma
• Merck Serono Sets Up Biotech Incubator in Israel
• Amgen to Buy KAI Pharmaceuticals for $315 Million

Keywords : acquisition Merck KGaA Millipore

Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany

Web: http://www.merck.de

• Legal
  • Terms and Conditions
  • Privacy Policy
  • Imprint
• Help
  • Contact
  • FAQ
  • Sitemap
• Participate
  • Register
  • Login
  • RSS-Feeds
• Related Publications
  • CITplus
  • IRFS&T
  • G.I.T. Laboratory Journal
  • PRO-4-PRO